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Background: TGF- is associated with worse outcome in cystic fibrosis (CF).
Results: TGF- causes mucociliary dysfunction by reducing airway surface liquid (ASL) due to decreased apical BK channel
activity and down-regulation of its  subunit LRRC26.
Conclusion: The TGF- inhibitor pirfenidone reverses ASL loss via BK and LRRC26 rescue.
Significance: Clinical trials could test the usefulness of pirfenidone in CF.
Transforming growth factor 1 (TGF-1) is not only elevated
in airways of cystic fibrosis (CF) patients, whose airways are
characterized by abnormal ion transport and mucociliary clear-
ance, but TGF-1 is also associated with worse clinical out-
comes. Effective mucociliary clearance depends on adequate
airway hydration, governed by ion transport. Apically
expressed, large-conductance, Ca2- and voltage-dependent K
(BK) channels play an important role in this process. In this
study, TGF-1 decreased airway surface liquid volume, ciliary
beat frequency, and BK activity in fully differentiated CF bron-
chial epithelial cells by reducing mRNA expression of the BK 
subunit leucine-rich repeat-containing protein 26 (LRRC26)
and its function. Although LRRC26 knockdown itself reduced
BK activity, LRRC26 overexpression partially reversed TGF-1-
induced BK dysfunction. TGF-1-induced airway surface liquid
volume hyper-absorption was reversed by the BK opener mallo-
toxin and the clinically useful TGF- signaling inhibitor pirfeni-
done. The latter increased BK activity via rescue of LRRC26.
Therefore, we propose that TGF-1-induced mucociliary dys-
function in CF airways is associated with BK inactivation related
to a LRRC26 decrease and is amenable to treatment with clini-
cally useful TGF-1 inhibitors.
Mucociliary clearance is an important innate defense mech-
anism (1, 2). The epithelium maintains an 7-m-high peri-
ciliary layer that allows effective ciliary beating to remove
mucus from the airways (3–5). Airway surface liquid (ASL)3
volume maintains this layer and hydrates mucus. Its depletion
leads to mucociliary dysfunction and subsequent lung disease
as exemplified by cystic fibrosis (CF).
Apical Cl secretion and Na absorption play critical roles in
ASL volume homeostasis (6). Due to a genetically defective cys-
tic fibrosis transmembrane conductance regulator (CFTR)
chloride channel, CF airway epithelia reveal reduced ASL vol-
ume that worsens under stress. Alternative pathways exist to
hydrate the airway surface via calcium-activated chloride chan-
nels. However, attempts to stimulate these channels and main-
tain ASL volume in CF have clinically failed (7). There are sev-
eral possible explanations for this outcome, including the short
duration of action of the agonist used. The focus here, however,
is on the driving force needed to secrete apical Cl.
ATP-induced apical K secretion, driven by apical large-
conductance, Ca2-activated and voltage-dependent potas-
sium (BK) channels, is critical for adequate ASL volume and
mucociliary clearance (8, 9). Apical K secretion facilitates Cl
efflux by hyperpolarizing the apical membrane and increasing
the driving force for Cl secretion by acting as the counter ion.
This creates a short circuit loop favoring airway surface hydra-
tion. In normal airway epithelial cells, inhibition of BK channels
or knockdown of the BK -subunit led to periciliary fluid col-
lapse as revealed by low ciliary beat frequency (CBF) that can be
fully rescued by apical fluid addition (8, 9).
Transforming growth factor 1 (TGF-1) is a modifier gene
in CF (10). Polymorphisms at codon 10 and 25 up-regulate
TGF-1 synthesis (11). These TGF-1 genotypes have been
associated with worse lung function in at least three indepen-
dent large clinical studies (12). Furthermore, bronchoalveolar
lavage fluid levels of TGF-1 were elevated in CF patients and
associated with diminished lung function and recent hospitali-
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zation (13). Furthermore, increased TGF-1 was found in con-
ditioned media of CF cells (14). TGF-1 also impairs therapeu-
tic rescue of CFTR in cystic fibrosis airway epithelial (CFBE)
cells (15, 16).
This study addressed the effect of TGF-1 on ion transport
and ASL volume regulation in CF epithelia, specifically focusing
on BK channels. TGF-1 reduced ASL volume and parameters
of mucociliary clearance, at least in part by decreasing BK activ-
ity. This was due to the down-regulation of leucine-rich repeat-
containing protein 26 (LRRC26), a subunit necessary for BK
function in non-excitable tissues (17). LRRC26 overexpression,
a BK opener, and the clinically used TGF-1 inhibitor pirfeni-
done overcame the detrimental effect of TGF-1. These data
provide the basis of a potential novel treatment approach for
patients suffering from CF.
Experimental Procedures
Chemicals and Solutions—All media, buffers, and most other
materials were purchased from Life Technologies and Sigma-
Aldrich. Recombinant TGF-1 was from R&D Systems (Min-
neapolis, MN), and pirfenidone was from Selleckchem (Hous-
ton, TX).
Cell Culture—CF lungs, homozygous for F508, were ob-
tained from transplant recipients, approved by our Institutional
Review Board. Airway epithelial cells were isolated as described
previously (18, 19). CFBE cells were used fully differentiated
after 4 weeks.
Quantitative PCR and Western Blots—mRNAs of interest
were quantified by PCR using a Bio-Rad iCycler and TaqMan
probes (Life Technologies), catalog number Hs02385555_g1
for LRRC26 and catalog number Hs00266938_m1 for
KCNMA1, the pore-forming subunit of BK (8). Western blots
were performed according to published methods (8). The fol-
lowing antibodies were used for BK: immunoprecipitation with
polyclonal AP107 anti- BK subunit antibody (Alomone Labs),
probing with monoclonal anti- BK subunit antibody (clone
L6/60, NeuroMab, Antibodies Inc.). The polyclonal anti-rabbit
LRRC26 antibody was from Santa Cruz Biotechnology (sc-
102015 V19) and used at a dilution of 1:200.
Ussing Chamber Electrophysiology—Fully differentiated CFBE
cells on Snapwell filters were mounted in Ussing chambers
(EasyMount chamber) connected to a VCC MC6 voltage clamp
unit (Physiologic Instruments, San Diego, CA). Data were
acquired as described previously from intact and basolaterally
permeabilized cell layers (8). Apical K currents were mea-
sured in the presence of apically applied 10 M amiloride and 30
min after basolateral permeabilization using 20 M amphoter-
icin B, 10 M valinomycin, and 10 M nigericin, using a baso-
lateral to apical K gradient (8).
LRRC26 Knockdown—Using calcium phosphate co-precipi-
tation (Clontech Laboratories, Inc.), lentiviruses were prepared
by co-transfecting HEK 293T cells with pLKO.1-puro-express-
ing LRRC26 shRNA (TRCN0000245794; MISSIONRNAi from
Sigma-Aldrich) and packaging DNA plasmids. Virus-contain-
ing medium was collected, concentrated by polyethylene glycol
(11%) precipitation, and stored at 80 °C. An estimation of the
virus titer was performed using the p24 HIV antigen ELISA kit
(PerkinElmer). Dedifferentiated cells were used for infections.
At the time of plating the cells on Transwell inserts, virus was
added at a ratio of 100 ng/500,000 cells in bronchial epithelial
growth medium containing Polybrene (2 g/ml). The infection
was carried out overnight, at 37 °C in 5% CO2. The following
day, virus was removed, and bronchial epithelial growth
medium was changed to air-liquid interface medium top and
bottom including puromycin until cells reached confluence,
when an air-liquid interface was created.
LRRC26 Overexpression—Full-length LRRC26 was amplified
from CF cells and cloned into the pCDH-EF1-MCS-IRES-Puro
vector from SBI. Viruses were made, and cells were infected and
selected as above.
Measurement of CBF—Washing of the apical surface was sus-
pended for the duration of the experiments. Cells were imaged
on a Zeiss Axiovert 200, equipped with differential interference
contrast optics. CBF was measured as described previously (29).
Measurements were done within a 0.5-cm radius from the cen-
ter (no influence of possible fluid menisci at the edges of the
cultures). CBF was measured before and after apical fluid
addition.
ASL Volume—ASL volumes from CFBE cells were estimated
by meniscus scanning (20). Cultures were washed with PBS 24 h
prior to measurements to clean the filters from mucus accu-
mulation that may interfere with the ASL reading. Scanned
menisci data were transformed to ASL volume using soft-
ware generously provided by Dr. Myerburg (University of
Pittsburgh).
Alternatively, the ASL of fully differentiated CFBE cells was
labeled with rhodamine-dextran (Life Technologies). ASL
height was measured by XZ confocal microscopy as described
previously (21) using a Leica SP5 confocal microscope with a
63 glycerol immersion lens.
Statistics—GraphPad Prism (GraphPad Software, San Diego,
CA) was used to analyze all results. Student’s t test or Mann-
Whitney tests were used to compare two groups as appropriate.
One-way analysis of variance was used for comparisons of more
than two groups followed by the appropriate post hoc tests. A
p  0.05 was accepted as significant.
Results
TGF-1 Decreases ASL Volume and CBF in CFBE Cells—ASL
volume was measured by meniscus scanning (20) in fully differ-
entiated, homozygous F508 CFBE cells. Cells treated basolat-
erally with TGF-1 (10 ng/ml) revealed fluid absorption both
during the first 20 h and during the subsequent 5-h time win-
dow (Fig. 1A), whereas control cells switched to net fluid secre-
tion in this 5-h period. TGF-1 also resulted in a significant
CBF decrease (Fig. 1B). ASL volume homeostasis maintains an
appropriate periciliary layer height that allows normal ciliary
activity. Therefore, a CBF reduction rescued by adding apical
fluid is due to ASL volume loss. In fact, TGF-1-induced CBF
decreases were fully reversed by adding apical buffer (Fig. 1B),
indicating no direct TGF-1 effect on cilia.
TGF-1 Changes Transepithelial Ion Transport in CFBE
Cells—TGF-1 treatment significantly decreased transepithe-
lial voltage (TEV, Fig. 2A), baseline short circuit current (Isc, Fig.
2A), transepithelial resistance (TER, Fig. 2A), and amiloride-
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sensitive Isc (Fig. 2A) due to epithelial sodium channel activity,
an effect previously reported in alveolar epithelia (22).
TGF-1 Reduces ATP-induced Apical K Secretion in CFBE
Cells—Apical BK activity was measured by ATP-induced Isc
changes in basolaterally permeabilized CFBE cells exposed to a
serosal-mucosal K gradient and amiloride (8). TGF-1 signif-
icantly reduced ATP-stimulated BK activity (Fig. 2B).
To test whether TGF-1 treatment interfered with ATP-in-
duced Ca2 signaling that opens BK, we measured the change
in fura-2 fluorescence as an indicator of [Ca2]i (Fig. 2C).
TGF-1 did not reduce the Ca2 response to ATP, eliminating
the possibility that the decreased BK activity was due to a break-
down of the upstream signaling pathway.
TGF-1 treatment had no negative impact on the cellular
expression of the BK channel pore-forming -subunit. TGF-1
increased its mRNA and did not change protein expression
significantly (Fig. 3A). Control and TGF-1-treated cells
responded to 5 M of the BK opener NS11021 (23) with a sim-
ilar current change (Fig. 3B), suggesting that surface availability
of the channel was not affected by TGF-1.
TGF-1 Changes the Functional Expression of LRRC26 —BK
activity can be modified by the presence of  modulatory pro-
teins, most commonly LRRC26 (17, 24). In the presence of
LRRC26, the threshold for BK channel opening at physiological
membrane potentials is left-shifted and requires a thousandfold
lower [Ca2]i, namely 100 nM instead of 100 M (17). This shift
allows BK activity in non-excitatory cells. TGF-1 decreased
LRRC26 mRNA and protein expression significantly (Fig. 3C).
To evaluate whether these changes translated to altered func-
tional activity, the BK opener mallotoxin (MTX (5 M)) was
used. MTX potently shifts the conductance-voltage relation-
ship of BK channels to the left (25), but only in the absence of
LRRC26. Control CFBE cells did not respond to MTX, whereas
TGF-1-treated cells showed increased apical K secretion
upon MTX exposure (Fig. 3D). Therefore, LRRC26 was also
functionally decreased in TGF-1-treated cells, leading to
decreased apical activity of BK channels.
TGF-1 and Paxilline Decrease ASL Volume in CFBE Cells—
Confocal microscopy was used to confirm the effects of
TGF-1 and BK channel inhibitors on ASL height (Fig. 4A).
Either 20 h of TGF-1 alone or the combination of paxilline
with TGF-1 pretreatment reduced ASL height relative to con-
trol (Fig. 4, A and B). The presence of the BK opener MTX
alleviated the effects of TGF-1.
LRRC26 Knockdown Decreases BK Activity—LRRC26 was
knocked down using shRNA-expressing lentiviruses. Quantita-
tive PCR showed a significant decrease of LRRC26 expression
in fully differentiated CFBE cells after they were infected in an
FIGURE 1. TGF-1 causes excessive ASL volume absorption in CFBE cells. White bars, control cells. Black bars, TGF-1-treated cells (10 ng/ml). Error bars:
mean  S.E. A, ASL volume measurements by meniscus refractometry. Experimental design was as follows. Cells were apically washed (ap. wash), and 10 ng/ml
TGF-1 was applied basolaterally at day 0. ASL volume was measured at 0, 20, and 25 h. Volume changes were expressed as absorption (positive values) or
secretion (negative values). White bars, vehicle; black bars, TGF-1-treated cells; 3 filters from 3 different donors were used in each experimental set. TGF-1
causes excessive ASL absorption in CFBE lungs. by Student’s t test. B, CBF measurements. Experimental design was as follows. Measurements were made before
(treated) and after (recovered) apical buffer addition. CBF measurements of 5 filters from 3 different lungs were made. *, p  0.05, ***, p  0.001 by Student’s
t test.
FIGURE 2. TGF-1 causes decreases in ATP-induced apical K secretion in CFBE cells. A, white bars, control cells; black bars, TGF-1-treated cells (10 ng/ml).
From left to right: transepithelial voltage (TEV) measurements in Ussing chambers with symmetrical Krebs-Henseleit buffer; baseline Isc; transepithelial resis-
tance (TER); and amiloride-sensitive Isc (10 M). *, p  0.05, **, p  0.01 by Student’s t test. Numbers of filters used are indicated in parentheses below each bar.
B, ATP-induced Isc changes in basolaterally permeabilized CFBE cells exposed to a basolateral-apical K
 gradient and 10 M amiloride. C, effect of ATP on [Ca2]i,
estimated by the ratio (340 nm/380 nm) of emitted light (510 nm) from fura-2-loaded cells. Left: data plotted as mean  S.E. for 10 different cells. Gray line,
control; black line, TGF-1-treated cells. Right: summary of maximal changes.
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undifferentiated state (Fig. 5A). LRRC26 protein expression
was also reduced by a modest amount when assessed by West-
ern blotting (Fig. 5B; 0.7-fold control). As with TGF-1,
LRRC26 knockdown actually increased KCNMA1 mRNA
expression (Fig. 5C). Nevertheless, knockdown cells exhibited
decreased BK activity (Fig. 5D) and increased MTX sensitivity
(Fig. 5E). We could not quantify ASL volume in these cells using
the meniscus scanning technique because they were dry and
showed mucus accumulation on their surfaces without move-
ment (Fig. 5F), indicating ASL volume loss.
LRRC26 Overexpression Partially Reverses TGF-1-induced
BK Dysfunction—LRRC26 overexpression increased LRRC26
mRNA and protein expression as expected (Fig. 6, A and B).
LRRC26 overexpression also reversed TGF-1-induced BK
dysfunction (Fig. 6C). As seen with TGF-1 alone, the
increased LRRC26 protein expression did not change the TGF-
1-induecd increases in KCNMA1 mRNA expression, the
pore-forming subunit of BK. However, this increase did not
explain the rescued K current with LRRC26 overexpression
because the current was down with TGF-1 alone despite an
increase in KCNMA1 mRNA in the cells infected with the con-
trol plasmid.
Pirfenidone Reverses TGF-1-induced Mucociliary Dysfunc-
tion in CFBE Cells—In normal human airway epithelial cells,
the Smad3 inhibitor SIS3 (26), but not p38 MAP kinase or PIK
inhibitors, partially counteracted the TGF-1-induced impair-
ments of BK activity and CBF (not shown), indicating a Smad-
dependent mechanism. We therefore tested the clinically use-
ful Smad2/3 inhibitor pirfenidone in CFBE cells. Pirfenidone (1
mg/ml) rescued TGF-1-mediated BK dysfunction (Fig. 7A),
LRRC26 down-regulation (Fig. 7B), and reversed MTX sensi-
tivity (Fig. 7C). In addition, pirfenidone rescued TGF-1-medi-
ated CBF decreases (Fig. 7D) and reversed the prolonged ASL
volume absorption induced by TGF-1 (Fig. 7E).
Discussion
TGF-1 is a potent physiological cytokine that is involved in
differentiation and proliferation. TGF-1 is increased in CF
lung disease and associated with worse clinical outcome. Our
results indicate that TGF-1 decreased ASL volume and CBF in
FIGURE 3. TGF-1 decreases ATP-induced apical K secretion and reduces LRRC26 expression in CFBE cells. A, quantitative PCR of KCNMA1 mRNA
relative to GAPDH (1000). Equal amounts of protein from pooled CFBE lysates were immunoprecipitated with polyclonal AP107 anti- BK subunit antibody
(Alomone Labs), electrophoresed, transferred, and probed with the monoclonal anti- BK subunit antibody (clone L6/60, NeuroMab, Antibodies Inc.). TGF-1
increases KCNMA1 mRNA in a non-significant manner, but does not change the  BK subunit protein expression as assessed by immunoprecipitation (LB:
control precipitation without antibody). White bars, control cells. Black bars, TGF-1-treated cells (10 ng/ml). Numbers of filters used are indicated in parentheses
below each bar. B, quantified current changes induced by NS11021 (5 M), corresponding to BK opening, indicating that BK remains at the surface upon TGF-1
treatment. C, quantitative PCR and protein expression of LRRC26. Left: mRNA is shown relative to GAPDH (1000). Right: Western blot with pooled samples
showing a decrease in LRRC26 protein expression upon TGF-1 exposure. D, effect of 5 M MTX on apical K secretion in the presence of amiloride. Mallotoxin
activates BK channels only if LRRC26 is absent. Gray line, control; black line, TGF-1-treated cells. *, p  0.05 by Student’s t test.
FIGURE 4. TGF-1 reduces ASL height. A and B, confocal microscopy to measure ASL height using rhodamine-dextran. Cells were treated with 10 ng/ml
TGF-1, 5 M paxilline, 30 M NS1619, and 5 M MTX. A, XZ confocal images of ASL height. The white bar indicates a height of 8 m. ASL and cells were labeled
for better orientation. B, analysis of ASL height (in m) from 4 filters of 4 donors. MTX partially rescues TGF-1-indced ASL height decreases. PAX, paxilline.
*, p  0.05 between treatments by analysis of variance followed by Dunnett’s multiple comparison test.
TGF--induced Mucociliary and BK Dysfunction in CF
OCTOBER 16, 2015 • VOLUME 290 • NUMBER 42 JOURNAL OF BIOLOGICAL CHEMISTRY 25713
CFBE cells (Fig. 8). We found that TGF-1 reduced apical BK
activity and that this effect was mediated by decreased
expression of the  modulatory protein LRRC26, which
causes a shift of the voltage and [Ca2]i needed for activation
of BK (17) and thus enables BK activity in non-excitable cells.
Our results confirmed that BK activity is necessary for ASL
homeostasis (8) because the BK inhibitor paxilline decreased
ASL volume similarly to TGF-1. A BK opener was partially
able to rescue ASL homeostasis in TGF-1-treated CFBE
cells. However, potassium channel openers might be associ-
ated with toxicity in human beings when reaching the sys-
temic circulation. On the other hand, it was interesting to
note that a clinically useful TGF-1 signaling inhibitor, pir-
fenidone, partially reversed the adverse effects of TGF-1 on
ASL volume and CBF.
Thus, targeting TGF- signaling might have benefits as a
therapy in patients with CF. This is not only true for ASL vol-
ume but also for CFTR corrector therapies, because a BK-in-
FIGURE 5. Partial LRRC26 knockdown still decreases BK function. A–D, non-targeting shRNA expression (white bars) and LRRC26 shRNA expression (black
bars), both via lentivirus infection. Numbers of filters used are indicated in parentheses below each bar (p indicates pooled samples). *, p  0.05. A–E,
shRNA-mediated knockdown of LRRC26 expression results in decreased LRRC26 mRNA (A); reduced LRRC26 protein expression (pooled samples show
reduction to 0.7-fold control when corrected for actin, see inset; WB dens. actin corr., western blot densitometry corrected for actin) (B); increased KCNMA1
mRNA expression (C); BK dysfunction (D); and increased MTX responsiveness (E). F, LRRC26 shRNA dries out air-liquid interface surfaces. Shown are represen-
tative air-liquid interface cultures from non-targeting shRNA-infected cells (left) and LRRC26 shRNA-infected cells (right). The white bar is 12 mm. LRRC26 shRNA
causes mucus accumulation on the cell surface and cessation of mucociliary transport.
FIGURE 6. LRRC26 overexpression rescues TGF-1-induced decreases in BK currents. Numbers of filters used are indicated in parentheses below each bar
(p indicates pooled samples). *, p  0.05. White bars, control, black bars, TGF-1; light gray bars, LRRC26 overexpression; dark gray bars, LRRC26 overexpression
plus TGF-1 treatment. A, overexpression of LRRC26 increases mRNA (relative to GAPDH 1000) and prevents reduction of mRNA for LRRC26 upon TGF-1
treatment. B, quantification of the pooled samples using Western blots shows the same pattern as the mRNA (corrected for actin, see inset; WB dens. actin corr.,
western blot densitometry corrected for actin). C, Ussing chamber currents of permeabilized cells show a reduction in Isc in control cells exposed to TGF-1 and
lack of a decrease when the LRRC26 protein is overexpressed and thereby maintained even in the presence of TGF-1. Data are shown in relative values
because of variability between samples with respect to BK currents. D, although KCNMA1 mRNA is increased upon TGF-1 exposure, the BK current is
decreased (see panel C and Fig. 2). Therefore, TGF-1-mediated increases in KCNMA1 mRNA in LRRC26-overexpressing cells do not explain the rescue of BK
currents.
FIGURE 7. Pirfenidone partially rescues TGF-1-induced changes, including BK dysfunction, LRRC26 down-regulation, CBF decreases, and ASL vol-
ume absorption. A–E, white bars, control; light gray bars, pirfenidone; black bars, TGF-1; dark gray bars, TGF-1 plus pirfenidone. Pirfenidone partially rescues
TGF-1-mediated BK dysfunction (A) and LRRC26 mRNA reduction (B); reduces TGF-1-mediated MTX responsiveness (C); reverses TGF-1-mediated CBF
decreases (D); and reverses the sustained ASL volume absorption (E). *, p  0.05.
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duced increase in the driving force for Cl secretion would be
beneficial even for partially corrected CFTR.
How good are preclinical models in predicting clinical out-
come? The most commonly measured clinical outcome in CF
patients is a change in forced expiratory volume in the first
second (FEV1). As described previously, a good correlation
between preclinical data on ASL volume regulation in air-liquid
interface cultures, where ASL height was brought into the nor-
mal range (i.e.  7 m), and clinical outcome data was found
using ivacaftor (10% FEV1 improvement in G551D patients)
and inhaled hypertonic saline (3% improvement) (27, 28). Thus,
the data presented here suggest that pirfenidone could have a
significant clinical effect in CF patients. This medication is
Food and Drug Administration (FDA)-approved and therefore
relatively easily amenable to clinical testing.
In conclusion, we showed that BK activity is necessary for
ASL homoeostasis in non-stressed CFBE cells and found that
TGF-1 decreases BK activity by reducing functional LRRC26
expression. The use of BK openers has a significant rescuing
effect, but targeting TGF-1 signaling might pave the way for
novel therapies for the treatment of CF and could have clinically
measurable therapeutic effects via improved airway hydration.
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